Clinical Trial Update: HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients [Phase 4]

View source ↗

Summary

This clinical trial update reports on a Phase 4 study in chronic hepatitis B patients with low replicative infection, focusing on HBsAg loss and seroconversion …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN